RITUXIMAB AND HYALURONIDASE

RITUXIMAB AND HYALURONIDASE was reported 453 times

RITUXIMAB AND HYALURONIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 13 0.0568
1 SWOLLEN JOINT COUNT 12 0.0480
2 MEDICAL AID IN DYING 1 0.0417
3 PARANEOPLASTIC RASH 1 0.0357
4 FOLLICULAR LYMPHOMA STAGE IV 1 0.0244
5 INFUSION SITE EXFOLIATION 1 0.0192
6 BASOPHILIA 1 0.0133
7 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 12 0.0127
8 ROSAI-DORFMAN SYNDROME 1 0.0127
9 PORPHYRIA ACUTE 17 0.0118
10 LUPUS VULGARIS 13 0.0103
11 RETINITIS 15 0.0087
12 DEEP VEIN THROMBOSIS POSTOPERATIVE 16 0.0080
13 X-RAY ABNORMAL 13 0.0073
14 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4 0.0071
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
16 DISLOCATION OF VERTEBRA 13 0.0057
17 B-LYMPHOCYTE COUNT INCREASED 1 0.0054
18 UPPER MOTOR NEURONE LESION 1 0.0045
19 BONE EROSION 16 0.0045
20 SWOLLEN JOINT COUNT INCREASED 13 0.0041
21 FACET JOINT SYNDROME 13 0.0040
22 PERIPHERAL VENOUS DISEASE 16 0.0039
23 TOTAL LUNG CAPACITY INCREASED 1 0.0037
24 INTERCEPTED PRODUCT STORAGE ERROR 13 0.0036
25 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
26 BLOOD VISCOSITY DECREASED 1 0.0030
27 RHEUMATIC FEVER 13 0.0029
28 ASTHMA EXERCISE INDUCED 1 0.0029
29 HYPOCHOLESTEROLAEMIA 1 0.0028
30 BREAST CANCER STAGE III 18 0.0028
31 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 16 0.0025
32 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
33 SINUS RHYTHM 1 0.0023
34 DUODENAL ULCER PERFORATION 17 0.0023
35 INTERCEPTED DRUG ADMINISTRATION ERROR 1 0.0023
36 RHEUMATOID FACTOR POSITIVE 13 0.0022
37 OESOPHAGEAL INFECTION 1 0.0022
38 ALLERGY TO ARTHROPOD STING 1 0.0022
39 INFUSION SITE HAEMATOMA 1 0.0021
40 WALKING AID USER 13 0.0020
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 14 0.0020
42 AORTIC VALVE CALCIFICATION 1 0.0019
43 ABDOMINAL INJURY 1 0.0019
44 C-REACTIVE PROTEIN ABNORMAL 12 0.0019
45 EXOSTOSIS 16 0.0018
46 INFUSION SITE REACTION 5 0.0017
47 HELICOBACTER INFECTION 17 0.0017
48 OPEN ANGLE GLAUCOMA 1 0.0016
49 FOLLICULITIS 17 0.0016
50 MONOCYTOSIS 1 0.0016
51 MUSCLE INJURY 13 0.0016
52 INFUSION SITE IRRITATION 2 0.0016
53 MITRAL VALVE CALCIFICATION 1 0.0016
54 HYPERCHOLESTEROLAEMIA 15 0.0016
55 GRIP STRENGTH DECREASED 13 0.0015
56 FOOT DEFORMITY 16 0.0014
57 LUPUS-LIKE SYNDROME 13 0.0014
58 LIP DRY 13 0.0014
59 OVERLAP SYNDROME 1 0.0014
60 CERVICAL RADICULOPATHY 1 0.0014
61 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
62 GRANULOMA ANNULARE 1 0.0014
63 AUTOIMMUNE DISORDER 13 0.0013
64 WOUND INFECTION 14 0.0013
65 AORTIC DISORDER 1 0.0013
66 PRODUCT CONFUSION 1 0.0013
67 LIP ERYTHEMA 1 0.0013
68 BURSITIS 15 0.0012
69 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
70 FOLLICULAR LYMPHOMA 1 0.0011
71 PEMPHIGUS 14 0.0011
72 JOINT RANGE OF MOTION DECREASED 15 0.0011
73 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
74 ANAEMIA OF CHRONIC DISEASE 1 0.0011
75 C-REACTIVE PROTEIN 1 0.0011
76 DRUG TOLERANCE DECREASED 3 0.0011
77 HAND DEFORMITY 14 0.0011
78 WEIGHT FLUCTUATION 11 0.0011
79 SKIN TEXTURE ABNORMAL 1 0.0010
80 BONE SWELLING 1 0.0010
81 PERICARDITIS 17 0.0010
82 INFUSION SITE DISCOMFORT 1 0.0010
83 ONYCHOMADESIS 4 0.0010
84 INFUSION SITE PRURITUS 3 0.0009
85 SUSPECTED OFF LABEL USE 4 0.0009
86 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
87 PUSTULAR PSORIASIS 3 0.0009
88 INTERCEPTED MEDICATION ERROR 4 0.0009
89 OPTIC NERVE INJURY 1 0.0009
90 HIP ARTHROPLASTY 13 0.0008
91 LOWER LIMB FRACTURE 16 0.0008
92 OBESITY 13 0.0008
93 SCIATICA 13 0.0008
94 ALLERGY TO CHEMICALS 1 0.0008
95 HEPATIC CIRRHOSIS 15 0.0008
96 PULMONARY FIBROSIS 15 0.0008
97 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
98 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
99 SYNOVITIS 13 0.0007
100 EAR INFECTION 18 0.0007
101 HAEMOGLOBIN INCREASED 3 0.0007
102 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
103 BLEPHAROSPASM 4 0.0006
104 FREQUENT BOWEL MOVEMENTS 17 0.0006
105 PNEUMONIA VIRAL 2 0.0006
106 GLOSSODYNIA 14 0.0006
107 IRRITABLE BOWEL SYNDROME 13 0.0006
108 MEDICAL PROCEDURE 1 0.0006
109 MITRAL VALVE PROLAPSE 1 0.0006
110 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
111 MALIGNANT PLEURAL EFFUSION 1 0.0006
112 MILIARIA 1 0.0006
113 EAR PRURITUS 2 0.0006
114 KNEE ARTHROPLASTY 12 0.0006
115 BREAST CYST 1 0.0006
116 HYPERACUSIS 2 0.0005
117 FIBROMYALGIA 13 0.0005
118 LIVER INJURY 13 0.0005
119 SKIN WARM 3 0.0005
120 LABORATORY TEST ABNORMAL 15 0.0005
121 WOUND 14 0.0005
122 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
123 NO ADVERSE EVENT 88 0.0005
124 BODY TEMPERATURE FLUCTUATION 1 0.0005
125 TYPE 2 DIABETES MELLITUS 16 0.0005
126 MIDDLE EAR EFFUSION 1 0.0005
127 GASTROINTESTINAL ULCER 1 0.0005
128 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
129 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
130 CHRONIC GASTRITIS 1 0.0004
131 OSTEOPOROSIS 18 0.0004
132 ORAL PRURITUS 1 0.0004
133 NIGHT SWEATS 14 0.0004
134 PERFORMANCE STATUS DECREASED 2 0.0004
135 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
136 PSORIATIC ARTHROPATHY 17 0.0004
137 DEVICE INFUSION ISSUE 1 0.0004
138 CATHETER SITE HAEMORRHAGE 1 0.0004
139 PLATELET DISORDER 1 0.0004
140 IMPAIRED HEALING 13 0.0004
141 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
142 LIPOMA 1 0.0004
143 INJECTION SITE DISCOMFORT 4 0.0004
144 JOINT DISLOCATION 4 0.0004
145 DELIRIUM 13 0.0004
146 RECTAL HAEMORRHAGE 16 0.0004
147 BACK INJURY 4 0.0004
148 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
149 PANCREATITIS 19 0.0004
150 TRICHORRHEXIS 1 0.0004
151 INFUSION SITE ERYTHEMA 3 0.0004
152 NEUTROPHIL COUNT ABNORMAL 1 0.0004
153 OSTEOARTHRITIS 15 0.0004
154 GENERALISED ERYTHEMA 2 0.0004
155 HYPERTONIC BLADDER 1 0.0003
156 NECK INJURY 1 0.0003
157 MYOSITIS 3 0.0003
158 INJECTION SITE DISCOLOURATION 4 0.0003
159 INFUSION SITE SWELLING 2 0.0003
160 INFUSION RELATED REACTION 21 0.0003
161 LIVER DISORDER 14 0.0003
162 ROAD TRAFFIC ACCIDENT 13 0.0003
163 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
164 INFLAMMATORY BOWEL DISEASE 3 0.0003
165 COELIAC DISEASE 3 0.0003
166 HYPOGAMMAGLOBULINAEMIA 2 0.0003
167 FEELING HOT 18 0.0003
168 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
169 COLITIS ULCERATIVE 13 0.0003
170 HYPOPNOEA 1 0.0003
171 NEOPLASM PROGRESSION 10 0.0003
172 LUNG DISORDER 14 0.0003
173 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
174 STOMATITIS 17 0.0003
175 ILL-DEFINED DISORDER 17 0.0003
176 BLOOD CHOLESTEROL INCREASED 13 0.0003
177 DISCOMFORT 17 0.0003
178 INFLAMMATION 14 0.0003
179 IMMUNODEFICIENCY 4 0.0003
180 THYROID MASS 1 0.0003
181 REHABILITATION THERAPY 1 0.0003
182 OEDEMA 14 0.0003
183 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
184 ARTHROPATHY 14 0.0003
185 BLISTER 14 0.0002
186 TRIGEMINAL NEURALGIA 1 0.0002
187 MUSCULOSKELETAL PAIN 13 0.0002
188 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
189 WHEEZING 14 0.0002
190 SWELLING 22 0.0002
191 AORTIC VALVE INCOMPETENCE 1 0.0002
192 OROPHARYNGEAL DISCOMFORT 2 0.0002
193 HEPATIC ENZYME INCREASED 15 0.0002
194 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
195 IMMUNE THROMBOCYTOPENIA 1 0.0002
196 RENAL FUNCTION TEST ABNORMAL 1 0.0002
197 MASS 3 0.0002
198 MIGRAINE 20 0.0002
199 CONTUSION 20 0.0002
200 RASH VESICULAR 1 0.0002
201 PRESCRIBED OVERDOSE 4 0.0002
202 ARTHRITIS 16 0.0002
203 ABDOMINAL TENDERNESS 1 0.0002
204 PRESCRIBED UNDERDOSE 4 0.0002
205 FLUID INTAKE REDUCED 1 0.0002
206 AMNESIA 13 0.0002
207 PREGNANCY 4 0.0002
208 INJURY 14 0.0002
209 MOBILITY DECREASED 14 0.0002
210 INJECTION SITE WARMTH 4 0.0002
211 LYMPHOMA 3 0.0002
212 VISUAL IMPAIRMENT 24 0.0002
213 JOINT STIFFNESS 5 0.0002
214 GASTROINTESTINAL DISORDER 16 0.0002
215 PRODUCT STORAGE ERROR 15 0.0002
216 SINUSITIS 17 0.0002
217 INJECTION SITE RASH 5 0.0002
218 DYSPEPSIA 16 0.0002
219 DRY MOUTH 13 0.0002
220 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
221 HAEMOGLOBIN ABNORMAL 1 0.0002
222 INJECTION SITE INDURATION 2 0.0002
223 HERPES SIMPLEX 1 0.0002
224 BRONCHIECTASIS 1 0.0001
225 MUSCULOSKELETAL STIFFNESS 13 0.0001
226 SINUS CONGESTION 2 0.0001
227 ULCER HAEMORRHAGE 1 0.0001
228 HYPERTRANSAMINASAEMIA 1 0.0001
229 FORMICATION 1 0.0001
230 SKIN REACTION 2 0.0001
231 DUODENAL ULCER 1 0.0001
232 RHEUMATOID ARTHRITIS 16 0.0001
233 DIVERTICULUM 1 0.0001
234 METASTASIS 1 0.0001
235 ANOSMIA 2 0.0001
236 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
237 RESPIRATORY DISORDER 4 0.0001
238 ASTHMA 15 0.0001
239 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
240 OEDEMA PERIPHERAL 16 0.0001
241 HYPERTHERMIA 1 0.0001
242 EPILEPSY 4 0.0001
243 HAEMOLYSIS 1 0.0001
244 INJECTION SITE ERYTHEMA 16 0.0001
245 SENSORY DISTURBANCE 2 0.0001
246 MUSCULAR WEAKNESS 14 0.0001
247 POST PROCEDURAL INFECTION 1 0.0001
248 HICCUPS 1 0.0001
249 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
250 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
251 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
252 BREAST CANCER STAGE II 1 0.0001
253 EOSINOPHIL COUNT INCREASED 1 0.0001
254 LIVE BIRTH 1 0.0001
255 CELLULITIS 6 0.0001
256 DISEASE PROGRESSION 14 0.0001
257 INFECTION 17 0.0001
258 FACIAL PARALYSIS 1 0.0001
259 PRODUCT CONTAINER ISSUE 1 0.0001
260 PSEUDOMONAS INFECTION 1 0.0001
261 INJECTION SITE REACTION 8 0.0001
262 RASH 50 0.0001
263 NAIL DISORDER 1 0.0001
264 TUMOUR LYSIS SYNDROME 1 0.0001
265 HYPOAESTHESIA 17 0.0001
266 WRONG DRUG ADMINISTERED 1 0.0001
267 ANAL INCONTINENCE 1 0.0001
268 HEAVY MENSTRUAL BLEEDING 1 0.0001
269 PERIPHERAL SWELLING 17 0.0001
270 C-REACTIVE PROTEIN INCREASED 4 0.0001
271 MEMORY IMPAIRMENT 15 0.0001
272 PNEUMONIA BACTERIAL 1 0.0001
273 BRAIN NEOPLASM 1 0.0001
274 NERVE COMPRESSION 1 0.0001
275 PRODUCT DISTRIBUTION ISSUE 1 0.0001
276 FEELING COLD 3 0.0001
277 JOINT SWELLING 13 0.0001
278 ABDOMINAL DISCOMFORT 18 0.0001
279 ERYTHEMA 22 0.0001
280 ABDOMINAL PAIN UPPER 22 0.0001
281 PHOTOPHOBIA 2 0.0001
282 LEUKAEMIA 1 0.0001
283 CONFUSIONAL STATE 17 0.0001
284 ATELECTASIS 1 0.0001
285 EAR PAIN 2 0.0001
286 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
287 URTICARIA 17 0.0001
288 LIGAMENT SPRAIN 1 0.0001
289 HYPERTENSION 21 0.0001
290 NEUTROPHIL COUNT INCREASED 1 0.0001
291 NASOPHARYNGITIS 18 0.0001
292 INITIAL INSOMNIA 1 0.0001
293 PRODUCT PREPARATION ERROR 2 0.0001
294 HYPERSENSITIVITY 18 0.0001
295 TEMPERATURE INTOLERANCE 1 0.0001
296 DRUG-INDUCED LIVER INJURY 3 0.0001
297 PARAESTHESIA 15 0.0001
298 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
299 SCRATCH 1 0.0001
300 DECREASED APPETITE 22 0.0001
301 CHILLS 11 0.0001
302 OFF LABEL USE 82 0.0001
303 HEREDITARY ANGIOEDEMA 1 0.0001
304 LIVER FUNCTION TEST INCREASED 2 0.0001
305 TREATMENT NONCOMPLIANCE 5 0.0001
306 ABDOMINAL PAIN 21 0.0001
307 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
308 INTESTINAL PERFORATION 1 0.0001
309 THERAPY NON-RESPONDER 4 0.0001
310 DERMATITIS CONTACT 1 0.0001
311 VASCULITIS 1 0.0001
312 PRODUCT PRESCRIBING ERROR 2 0.0001
313 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
314 HYPERLIPIDAEMIA 1 0.0001
315 PNEUMONIA 27 0.0001
316 MUSCLE SPASMS 15 0.0001
317 CYTOPENIA 1 0.0001
318 CARDIOMEGALY 1 0.0001
319 CHEST PAIN 15 0.0001
320 CYST 1 0.0001
321 AGEUSIA 2 0.0001
322 HYPOPHAGIA 2 0.0001
323 INFUSION SITE PAIN 1 0.0001
324 HAEMATOMA 2 0.0001
325 DIPLOPIA 2 0.0001
326 ALOPECIA 15 0.0001
327 SARS-COV-2 TEST POSITIVE 1 0.0001
328 HAIR TEXTURE ABNORMAL 1 0.0001
329 MENSTRUATION IRREGULAR 2 0.0001
330 NEUTROPHIL COUNT DECREASED 3 0.0001
331 TACHYPNOEA 1 0.0001
332 GAIT DISTURBANCE 14 0.0001
333 DRUG INTOLERANCE 7 0.0001
334 NECK PAIN 4 0.0001
335 CARPAL TUNNEL SYNDROME 1 0.0001
336 DEVICE OCCLUSION 1 0.0001
337 SLEEP DISORDER 5 0.0001
338 PAIN IN JAW 2 0.0001
339 DEPRESSION 16 0.0001
340 HYPOKINESIA 1 0.0001
341 CARDIOMYOPATHY 1 0.0001
342 THROAT IRRITATION 3 0.0001
343 ANXIETY 19 0.0001
344 BLOOD COUNT ABNORMAL 1 0.0001
345 HYPOKALAEMIA 3 0.0001
346 WEIGHT DECREASED 18 0.0001
347 INSOMNIA 17 0.0001
348 BRAIN FOG 1 0.0001
349 RESPIRATORY TRACT CONGESTION 1 0.0001
350 WEIGHT INCREASED 14 0.0001
351 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
352 MANIA 1 0.0001
353 PYREXIA 21 0.0001
354 SKIN DISORDER 2 0.0001
355 PRURITUS 23 0.0001
356 GAIT INABILITY 2 0.0001
357 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
358 SCAR 1 0.0001
359 MUSCULOSKELETAL DISCOMFORT 1 0.0001
360 EOSINOPHILIA 1 0.0001
361 HEART RATE DECREASED 2 0.0001
362 LYMPHOCYTE COUNT DECREASED 1 0.0001
363 DRUG ERUPTION 1 0.0001
364 PLATELET COUNT DECREASED 6 0.0001
365 GOUT 1 0.0001
366 ADVERSE DRUG REACTION 5 0.0001
367 TOOTHACHE 1 0.0001
368 MALAISE 24 0.0001
369 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
370 ANAPHYLACTIC REACTION 3 0.0001
371 ADVERSE EVENT 5 0.0001
372 BLOOD GLUCOSE ABNORMAL 1 0.0001
373 DIZZINESS 27 0.0001
374 INJECTION SITE MASS 2 0.0001
375 MEDICATION ERROR 3 0.0001
376 EYE SWELLING 2 0.0001
377 PAIN 33 0.0001
378 MIDDLE INSOMNIA 1 0.0001
379 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
380 NEUROPATHY PERIPHERAL 5 0.0001
381 INCREASED APPETITE 1 0.0001
382 HERPES ZOSTER 3 0.0001
383 INJECTION SITE PAIN 16 0.0001
384 NEUTROPENIA 7 0.0001
385 DISABILITY 1 0.0001
386 SINUS DISORDER 1 0.0001
387 HAEMATOCRIT DECREASED 1 0.0001
388 PRODUCT ADMINISTRATION ERROR 1 0.0000
389 CONDITION AGGRAVATED 15 0.0000
390 TASTE DISORDER 1 0.0000
391 FLUSHING 5 0.0000
392 TREATMENT FAILURE 4 0.0000
393 MOUTH ULCERATION 1 0.0000
394 SKIN EXFOLIATION 4 0.0000
395 VOMITING 22 0.0000
396 SKIN CANCER 1 0.0000
397 FATIGUE 36 0.0000
398 DYSPNOEA 26 0.0000
399 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
400 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
401 ANGIOEDEMA 2 0.0000
402 RASH MACULO-PAPULAR 1 0.0000
403 HEADACHE 28 0.0000
404 RASH PAPULAR 1 0.0000
405 NAUSEA 35 0.0000
406 ARTHRALGIA 18 0.0000
407 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
408 ASTHENIA 16 0.0000
409 PRODUCTIVE COUGH 2 0.0000
410 RASH ERYTHEMATOUS 2 0.0000
411 BLOOD PRESSURE FLUCTUATION 1 0.0000
412 MENTAL IMPAIRMENT 1 0.0000
413 PRESYNCOPE 1 0.0000
414 NEURALGIA 1 0.0000
415 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
416 PRODUCT COMPLAINT 1 0.0000
417 HEPATITIS 1 0.0000
418 CHEST DISCOMFORT 4 0.0000
419 LOSS OF CONSCIOUSNESS 5 0.0000
420 HYPERHIDROSIS 5 0.0000
421 ANAPHYLACTIC SHOCK 1 0.0000
422 DIARRHOEA 25 0.0000
423 RASH GENERALISED 1 0.0000
424 ABDOMINAL DISTENSION 4 0.0000
425 NERVOUSNESS 2 0.0000
426 PAIN OF SKIN 1 0.0000
427 RASH PRURITIC 2 0.0000
428 PALLOR 1 0.0000
429 PNEUMONITIS 1 0.0000
430 VISION BLURRED 5 0.0000
431 HAEMOPTYSIS 1 0.0000
432 PANCYTOPENIA 2 0.0000
433 EYE PAIN 2 0.0000
434 RED BLOOD CELL COUNT DECREASED 1 0.0000
435 LIVER FUNCTION TEST ABNORMAL 1 0.0000
436 BONE PAIN 2 0.0000
437 CATARACT 2 0.0000
438 VERTIGO 2 0.0000
439 HEAD INJURY 1 0.0000
440 CYSTITIS 1 0.0000
441 HYPOTHYROIDISM 1 0.0000
442 MOVEMENT DISORDER 1 0.0000
443 HIP FRACTURE 1 0.0000
444 SWELLING FACE 2 0.0000
445 BLOOD CREATININE INCREASED 2 0.0000
446 FEBRILE NEUTROPENIA 2 0.0000
447 LIP SWELLING 1 0.0000
448 URINARY RETENTION 1 0.0000
449 NEOPLASM MALIGNANT 2 0.0000
450 HYPOTENSION 6 0.0000
451 URINARY TRACT INFECTION 5 0.0000
452 NIGHTMARE 1 0.0000
453 COUGH 8 0.0000
454 BURNING SENSATION 2 0.0000
455 HYPERKALAEMIA 1 0.0000
456 LYMPHADENOPATHY 1 0.0000
457 BRONCHITIS 2 0.0000
458 THROMBOCYTOPENIA 3 0.0000
459 EPISTAXIS 2 0.0000
460 DYSPNOEA EXERTIONAL 1 0.0000
461 HOT FLUSH 2 0.0000
462 INTESTINAL OBSTRUCTION 1 0.0000
463 UNEVALUABLE EVENT 2 0.0000
464 INJECTION SITE SWELLING 2 0.0000
465 HOSPITALISATION 4 0.0000
466 INJECTION SITE HAEMORRHAGE 2 0.0000
467 INFLUENZA LIKE ILLNESS 2 0.0000
468 POLLAKIURIA 1 0.0000
469 PAIN IN EXTREMITY 7 0.0000
470 MYALGIA 4 0.0000
471 DEVICE DISLOCATION 1 0.0000
472 TACHYCARDIA 2 0.0000
473 DEATH 19 0.0000
474 SKIN IRRITATION 1 0.0000
475 RENAL DISORDER 1 0.0000
476 COGNITIVE DISORDER 1 0.0000
477 CARDIAC DISORDER 2 0.0000
478 OCULAR HYPERAEMIA 1 0.0000
479 INTERSTITIAL LUNG DISEASE 1 0.0000
480 HYPOGLYCAEMIA 1 0.0000
481 ATRIAL FIBRILLATION 2 0.0000
482 LEUKOPENIA 1 0.0000
483 SYNCOPE 2 0.0000
484 FLUID RETENTION 1 0.0000
485 HAEMOGLOBIN DECREASED 2 0.0000
486 ILLNESS 2 0.0000
487 INFLUENZA 2 0.0000
488 OXYGEN SATURATION DECREASED 1 0.0000
489 FLATULENCE 1 0.0000
490 EYE IRRITATION 1 0.0000
491 DYSPHONIA 1 0.0000
492 PALPITATIONS 2 0.0000
493 NASAL CONGESTION 1 0.0000
494 PLEURAL EFFUSION 1 0.0000
495 PRODUCT USE ISSUE 3 0.0000
496 RENAL FAILURE 2 0.0000
497 BLOOD PRESSURE DECREASED 1 0.0000
498 INJECTION SITE PRURITUS 1 0.0000
499 PRODUCT QUALITY ISSUE 2 0.0000
500 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
501 THERAPY INTERRUPTED 1 0.0000
502 SKIN BURNING SENSATION 1 0.0000
503 CONSTIPATION 3 0.0000
504 RESPIRATORY FAILURE 1 0.0000
505 UNDERDOSE 1 0.0000
506 HALLUCINATION 1 0.0000
507 BLOOD PRESSURE INCREASED 2 0.0000
508 BACK PAIN 3 0.0000
509 TREMOR 2 0.0000
510 FALL 4 0.0000
511 RENAL IMPAIRMENT 1 0.0000
512 BALANCE DISORDER 1 0.0000
513 COVID-19 2 0.0000
514 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
515 BREAST CANCER 1 0.0000
516 DRUG INEFFECTIVE 14 0.0000
517 ANAEMIA 2 0.0000
518 PRODUCT DOSE OMISSION ISSUE 3 0.0000
519 SOMNOLENCE 2 0.0000
520 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
521 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
522 SEPSIS 1 0.0000
523 FEELING ABNORMAL 2 0.0000
524 EMOTIONAL DISTRESS 1 0.0000
525 DRUG INTERACTION 1 0.0000
526 DRUG DOSE OMISSION 1 0.0000
527 TOXICITY TO VARIOUS AGENTS 1 0.0000
528 CEREBROVASCULAR ACCIDENT 1 0.0000
529 BLOOD GLUCOSE INCREASED 1 0.0000